vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and EXPRO GROUP HOLDINGS N.V. (XPRO). Click either name above to swap in a different company.

EXPRO GROUP HOLDINGS N.V. is the larger business by last-quarter revenue ($382.1M vs $236.8M, roughly 1.6× CROSS COUNTRY HEALTHCARE INC). EXPRO GROUP HOLDINGS N.V. runs the higher net margin — 1.5% vs -35.0%, a 36.5% gap on every dollar of revenue. On growth, EXPRO GROUP HOLDINGS N.V. posted the faster year-over-year revenue change (-12.5% vs -23.6%). EXPRO GROUP HOLDINGS N.V. produced more free cash flow last quarter ($23.2M vs $16.1M). Over the past eight quarters, EXPRO GROUP HOLDINGS N.V.'s revenue compounded faster (-0.2% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Expro is an energy services provider headquartered in Houston, Texas, United States.

CCRN vs XPRO — Head-to-Head

Bigger by revenue
XPRO
XPRO
1.6× larger
XPRO
$382.1M
$236.8M
CCRN
Growing faster (revenue YoY)
XPRO
XPRO
+11.1% gap
XPRO
-12.5%
-23.6%
CCRN
Higher net margin
XPRO
XPRO
36.5% more per $
XPRO
1.5%
-35.0%
CCRN
More free cash flow
XPRO
XPRO
$7.1M more FCF
XPRO
$23.2M
$16.1M
CCRN
Faster 2-yr revenue CAGR
XPRO
XPRO
Annualised
XPRO
-0.2%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
XPRO
XPRO
Revenue
$236.8M
$382.1M
Net Profit
$-82.9M
$5.8M
Gross Margin
Operating Margin
-30.2%
3.1%
Net Margin
-35.0%
1.5%
Revenue YoY
-23.6%
-12.5%
Net Profit YoY
-2109.7%
-74.9%
EPS (diluted)
$-2.56
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
XPRO
XPRO
Q4 25
$236.8M
$382.1M
Q3 25
$250.1M
$411.4M
Q2 25
$274.1M
$422.7M
Q1 25
$293.4M
$390.9M
Q4 24
$309.9M
$436.8M
Q3 24
$315.1M
$422.8M
Q2 24
$339.8M
$469.6M
Q1 24
$379.2M
$383.5M
Net Profit
CCRN
CCRN
XPRO
XPRO
Q4 25
$-82.9M
$5.8M
Q3 25
$-4.8M
$14.0M
Q2 25
$-6.7M
$18.0M
Q1 25
$-490.0K
$13.9M
Q4 24
$-3.8M
$23.0M
Q3 24
$2.6M
$16.3M
Q2 24
$-16.1M
$15.3M
Q1 24
$2.7M
$-2.7M
Gross Margin
CCRN
CCRN
XPRO
XPRO
Q4 25
Q3 25
20.4%
Q2 25
20.4%
Q1 25
20.0%
Q4 24
Q3 24
20.4%
Q2 24
20.8%
Q1 24
20.4%
Operating Margin
CCRN
CCRN
XPRO
XPRO
Q4 25
-30.2%
3.1%
Q3 25
-2.4%
6.4%
Q2 25
-2.1%
7.7%
Q1 25
-0.3%
2.6%
Q4 24
-1.1%
7.3%
Q3 24
0.9%
6.2%
Q2 24
-5.7%
5.9%
Q1 24
0.8%
2.2%
Net Margin
CCRN
CCRN
XPRO
XPRO
Q4 25
-35.0%
1.5%
Q3 25
-1.9%
3.4%
Q2 25
-2.4%
4.3%
Q1 25
-0.2%
3.6%
Q4 24
-1.2%
5.3%
Q3 24
0.8%
3.8%
Q2 24
-4.7%
3.3%
Q1 24
0.7%
-0.7%
EPS (diluted)
CCRN
CCRN
XPRO
XPRO
Q4 25
$-2.56
$0.05
Q3 25
$-0.15
$0.12
Q2 25
$-0.20
$0.16
Q1 25
$-0.02
$0.12
Q4 24
$-0.13
$0.20
Q3 24
$0.08
$0.14
Q2 24
$-0.47
$0.13
Q1 24
$0.08
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
XPRO
XPRO
Cash + ST InvestmentsLiquidity on hand
$108.7M
$196.1M
Total DebtLower is stronger
$79.1M
Stockholders' EquityBook value
$322.8M
$1.5B
Total Assets
$449.0M
$2.3B
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
XPRO
XPRO
Q4 25
$108.7M
$196.1M
Q3 25
$99.1M
$197.9M
Q2 25
$81.2M
$206.8M
Q1 25
$80.7M
$179.3M
Q4 24
$81.6M
$183.0M
Q3 24
$64.0M
$165.7M
Q2 24
$69.6M
$133.5M
Q1 24
$5.2M
$163.2M
Total Debt
CCRN
CCRN
XPRO
XPRO
Q4 25
$79.1M
Q3 25
$99.1M
Q2 25
$121.1M
Q1 25
$121.1M
Q4 24
$121.1M
Q3 24
$121.1M
Q2 24
$121.1M
Q1 24
$40.0M
Stockholders' Equity
CCRN
CCRN
XPRO
XPRO
Q4 25
$322.8M
$1.5B
Q3 25
$408.1M
$1.5B
Q2 25
$412.2M
$1.5B
Q1 25
$418.2M
$1.5B
Q4 24
$419.0M
$1.5B
Q3 24
$424.7M
$1.5B
Q2 24
$433.3M
$1.5B
Q1 24
$462.4M
$1.3B
Total Assets
CCRN
CCRN
XPRO
XPRO
Q4 25
$449.0M
$2.3B
Q3 25
$538.2M
$2.3B
Q2 25
$553.8M
$2.3B
Q1 25
$576.2M
$2.3B
Q4 24
$589.3M
$2.3B
Q3 24
$597.4M
$2.3B
Q2 24
$602.9M
$2.3B
Q1 24
$648.4M
$2.0B
Debt / Equity
CCRN
CCRN
XPRO
XPRO
Q4 25
0.05×
Q3 25
0.07×
Q2 25
0.08×
Q1 25
0.08×
Q4 24
0.08×
Q3 24
0.08×
Q2 24
0.08×
Q1 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
XPRO
XPRO
Operating Cash FlowLast quarter
$18.2M
$57.1M
Free Cash FlowOCF − Capex
$16.1M
$23.2M
FCF MarginFCF / Revenue
6.8%
6.1%
Capex IntensityCapex / Revenue
0.9%
8.9%
Cash ConversionOCF / Net Profit
9.89×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$97.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
XPRO
XPRO
Q4 25
$18.2M
$57.1M
Q3 25
$20.1M
$63.2M
Q2 25
$4.2M
$48.4M
Q1 25
$5.7M
$41.5M
Q4 24
$24.2M
$97.4M
Q3 24
$7.5M
$55.3M
Q2 24
$82.4M
$-13.2M
Q1 24
$6.0M
$29.9M
Free Cash Flow
CCRN
CCRN
XPRO
XPRO
Q4 25
$16.1M
$23.2M
Q3 25
$17.9M
$39.0M
Q2 25
$2.3M
$27.2M
Q1 25
$3.8M
$8.4M
Q4 24
$21.7M
$53.0M
Q3 24
$6.3M
$23.3M
Q2 24
$79.6M
$-49.5M
Q1 24
$3.8M
$-801.0K
FCF Margin
CCRN
CCRN
XPRO
XPRO
Q4 25
6.8%
6.1%
Q3 25
7.2%
9.5%
Q2 25
0.8%
6.4%
Q1 25
1.3%
2.1%
Q4 24
7.0%
12.1%
Q3 24
2.0%
5.5%
Q2 24
23.4%
-10.5%
Q1 24
1.0%
-0.2%
Capex Intensity
CCRN
CCRN
XPRO
XPRO
Q4 25
0.9%
8.9%
Q3 25
0.9%
5.9%
Q2 25
0.7%
5.0%
Q1 25
0.6%
8.5%
Q4 24
0.8%
10.2%
Q3 24
0.4%
7.6%
Q2 24
0.8%
7.7%
Q1 24
0.6%
8.0%
Cash Conversion
CCRN
CCRN
XPRO
XPRO
Q4 25
9.89×
Q3 25
4.52×
Q2 25
2.69×
Q1 25
2.98×
Q4 24
4.23×
Q3 24
2.92×
3.40×
Q2 24
-0.86×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

XPRO
XPRO

NLA$130.3M34%
ESSA$116.3M30%
MENA$93.0M24%
Other$42.5M11%

Related Comparisons